Netherlands· NL-5adaaba6ae35

Raltegravir Rockmed Pharma 400 mg filmomhulde tabletten

A raltegravir product containing raltegravir kalium, registered in Netherlands by Rockmed Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC J05AJ01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about raltegravir kaliumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Raltegravir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AJ01 (raltegravir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search raltegravir products by name

Raltegravir · ATC J05AJ01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of raltegravir costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Raltegravir · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

CH Switzerland$18.61

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: RALTEGRAVIR KALIUM
Manufacturer: Rockmed Pharma B.V.
Country: Netherlands (NL)
ATC code: J05AJ01
ATC class: Raltegravir
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
135766

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for raltegravir.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check raltegravir against other medicines How interaction checks work

Raltegravir · interactions on record

55 records

15 severe
22 moderate
18 minor

Most severe, free to view

Magnesium carbonateA02AA01severe
Magnesium hydroxideA02AA04severe
Kombinationen von AluminiumsalzenA02AB10severe
Calcium carbonateA02AC01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Raltegravir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All raltegravir products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
Cyprus · Raltegravir Viatris
Germany · Raltegravir Axiromed, Raltegravir Beta
Denmark · Raltegravir Viatris, Raltegravir Zentiva
Estonia · Raltegravir Viatris, Raltegravir Zentiva
Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
Finland · Raltegravir Viatris, Raltegravir Zentiva
France · Raltegravir Biogaran, Raltégravir Biogaran
United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
Greece · Ralpecin, Raltegravir Viatris
Croatia · Raltegravir Viatris
Iceland · Isentress, Raltegravir Zentiva
Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
Liechtenstein · Isentress
Lithuania · Raltegravir Zentiva
Latvia · Raltegravir Viatris, Raltegravir Zentiva
Malta · Raltegravir Viatris
Norway · Isentress, Raltegravir Viatris
Poland · Raltegravir Viatris
Portugal · Raltegravir Mylan, Raltegravir Zentiva
Romania · Raltegravir Viatris, Raltegravir Zentiva
Sweden · Raltegravir Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fe229094-c9ef-40c6-98af-9456a09bfeee
GET /v1/drugs/fe229094-c9ef-40c6-98af-9456a09bfeee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h135766_smpc.pdf",
  "strength": null,
  "atc_label": "Raltegravir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135766",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMSTEARYLFUMARAAT",
    "POLOXAMEER 407",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "RALTEGRAVIR KALIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135766.pdf",
  "authorised_at": "2026/05/28",
  "procedure_number": "DE/H/8285/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135766",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about raltegravir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console